The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis

Muchtar, E., Sanchorawala, V., Hassan, H., Hegenbart, U., Schönland, S., Lee, H. C., Qazilbash, M., Kin, A., Zonder, J., Jacob, E., Buadi, F., Dispenzieri, A., Dingli, D., Arai, S., Chin, M., Chakraborty, R., Lentzsch, S., Magen, H., Shkury, E., … Gertz, M. (2025). The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post‐Transplant Outcomes in AL Amyloidosis. American Journal of Hematology. Portico. https://doi.org/10.1002/ajh.27685
Authors:
Eli Muchtar
Vaishali Sanchorawala
Hamza Hassan
Ute Hegenbart
Stefan Schönland
Hans C Lee
Muzaffar Qazilbash
Andrew Kin
Jeffrey Zonder
Eapen Jacob
Francis Buadi
Angela Dispenzieri
David Dingli
Sally Arai
Michelle Chin
Rajshekhar Chakraborty
Suzanne Lentzsch
Hila Magen
Eden Shkury
Caitlin Sarubbi
Heather Landau
Morie Gertz
Affiliated Authors:
Rajshekhar Chakraborty
Suzanne Lentzsch
Columbia Affiliation:
Author Keywords:
bmt
marrow/stem cell transplantation‐clinical results in myeloma
neoplasia‐myeloma and other plasma cell dyscrasias
elink
Publication Type:
Article
Unique ID:
10.1002/ajh.27685
PMID:
40214172
DOI:
10.1002/ajh.27685
Journal:
American Journal of Hematology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: